论文部分内容阅读
目的观察西帕依固龈液治疗药物性牙龈增生(DGO)的临床疗效。方法将临床上使用钙通道阻滞剂并诊断为药物性牙龈增生的18例患者经过牙周基础治疗后,随机分为观察组和对照组,每组各9例。两组均予牙周基础治疗,观察组给予西帕依固龈液含漱,对照组给予双氧水含漱,3个月后观察并对比两组受试者探诊深度(PD)、牙龈增生指数(GHI)、牙龈出血指数(SBI)和菌斑指数(PLI)的变化。结果治疗3个月后,两组PD、GHI、SBI、PLI均有所好转,但观察组明显优于对照组,差异有统计学意义(P<0.05)。结论西帕依固龈液对DGO具有较高的辅助治疗作用。
Objective To observe the clinical efficacy of Xipayi gingival fluid in the treatment of drug-induced gingival hyperplasia (DGO). Methods 18 cases of clinically using calcium channel blockers diagnosed as drug-induced gingival hyperplasia after periodontal basic treatment were randomly divided into observation group and control group, 9 cases in each group. The two groups were given basic periodontal treatment. The observation group was given cisapride gingival fluid gargle, the control group was given hydrogen peroxide rinse. After 3 months, the probing depth (PD), gingival hyperplasia index (GHI), gingival bleeding index (SBI) and plaque index (PLI). Results Three months after treatment, PD, GHI, SBI and PLI in both groups improved, but the observation group was significantly better than the control group, the difference was statistically significant (P <0.05). Conclusion Sipayi gingival fluid has a high adjuvant therapeutic effect on DGO.